Equity for cash HealthTech & MedTech accelerators
These healthtech programs invest cash for equity. The checks range from $30,000 to $220,000 and the equity taken runs from 3 to 8 percent, so the same label covers very different deals. Each record below spells out the instrument (priced stock, SAFE, or convertible note) and the stake in plain English, using only what the program itself publishes.
Showing 8 of 8 programs, plus 1 that has ended
| Check size | Equity | Terms | Format | Next window | Signal | |||
|---|---|---|---|---|---|---|---|---|
| AlphaLab Health Track (formerly AlphaLab Health)life sciences / healthcare (incl. neuroscience sub-track) | up to $100,000 | 3% | Equity for cash | PA | In person | None confirmed | Oct 1, 2026 | Verified |
| Health Wildcatters | $30,000 | 8% | Equity for cash | TX | Hybrid | None confirmed | Oct 1, 2026 | Verified |
| Healthworx Accelerator (formerly 1501 Health) | $25,000 | Not publishedHealthworx Accelerator (formerly 1501 Health) is run by Healthworx, the innovation and investment arm of CareFirst. Healthworx named Highmark and LifeBridge Health as accelerator partners in July 2024; the current partners page lists Highmark Ventures on the selection committee and does not mention LifeBridge. Each selected company receives a $25,000 investment; per the program guide, a company not raising a simultaneous round receives it as a SAFE note with a 25% discount rate and no valuation cap, with side-letter terms discussed during selection, so equity_pct is null. Stage 1 is a 12-week curriculum of virtual and in-person sessions; at the end of Stage 1, industry partners select cohort companies for Stage 2, nine months of guided mentorship toward commercial pilots (partnerships not assured). One cohort a year of about 20 companies. 2026 cohort applications are open and close October 9, 2026, per the program site. The former site 1501health.com still fails to load as of October 1, 2026 (TLS error). | Equity for cash | MD | Hybrid | None confirmed | Oct 1, 2026 | Verified |
| HeartX Cardiovascular Acceleratorcardiovascular digital health, medical devices and diagnostics | $150,000 up-front investment via SAFE or convertible note | Not publishedVirtual cardiovascular accelerator from HTA (formerly HealthTech Arkansas) and MedAxiom, an American College of Cardiology company. Five companies are chosen each year, and each gets at least one pilot project or clinical study with a cardiology practice in the HeartX coalition. Each company must accept a $150,000 up-front investment through a SAFE or convertible note, with the cap and discount negotiated with the HeartX team, and must also issue $50,000 in-kind investment positions to HTA and to MedAxiom in exchange for the pilot, network access and MedAxiom's services. Applicants need data from earlier pilots, at least $500,000 raised in external capital, and the ability to start enrolling patients within three months. The 2026 cohort of five was announced September 28, 2026 and kicks off at MedAxiom's CV Transforum in Denver in October 2026. City not printed on the program pages. | Equity for cash | AR | Remote | None confirmed | Oct 1, 2026 | Verified |
| Northwestern Medicine & Techstars Healthcare Accelerator | $220,000 | 5% minimum (5% common via CEA plus uncapped SAFE) | Equity for cash | IL | In person | Nov 18, 2026 | Oct 1, 2026 | Verified |
| Techstars AI Health BaltimoreAI in healthcare | $220,000 | 5% common stock via $20,000 convertible equity agreement, plus $200,000 uncapped MFN post-money SAFE (standard Techstars terms) | Equity for cash | MD | In person | Nov 18, 2026 | Oct 1, 2026 | Verified |
| Techstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic Statescare delivery / digital health | $220,000 | 5% common stock via $20,000 convertible equity agreement, plus $200,000 uncapped MFN post-money SAFE (standard Techstars terms) | Equity for cash | DC | In person | None confirmed | Oct 1, 2026 | Verified |
| ZeroTo510 Medical Device Acceleratormedical devices | $25,000 (plus $25,000 more for teams with a Memphis presence) | Not publishedRun by Epicenter (Memphis). Each company receives a $25,000 cash investment on entering the program, structured as a SAFE; an additional $25,000 is available for teams with a physical presence in Memphis (the homepage says for companies that locate in the Memphis area for at least 12 consecutive months). The program also provides $50,000 in services and perks. Founders are asked to reserve 5% of their company for mentors and/or board members they bring on; the program does not take that stake, and founders decide how to assign it. equity_pct null because the SAFE's cap and discount are not published. Intensive 13-week (90-day) program; typically 4 to 6 ventures per cohort; applicants need a plan for a foothold connection to Memphis. The former 'up to $150,000' headline no longer appears on the site (checked September 28, 2026). Fall 2026 applications are closed. | Equity for cash | TN | In person | None confirmed | Oct 1, 2026 | Verified |
Programs that have ended
| Check size | Equity | Terms | Format | Next window | Signal | |||
|---|---|---|---|---|---|---|---|---|
| Blueprint Health | Not publishedEnded: the site describes a three-month program and a standard agreement under which Blueprint Health received 6% of founder shares ('Is It Worth 6%' page). Its apply page, checked September 29, 2026, still says there are no plans to run a program in 2020 and to check back for a 2021 program; no later cohort, dates or application form appear on the site. Cash investment amount not stated, so null. | 6% | Equity for cash | NY | In person | None | Sep 29, 2026 | VerifiedProgram endedThe operator has said this program ended, or its program pages are gone and it has shown no activity for two years or more. We keep the record so its history stays visible. |
Widen the search
This list is limited to equity for cash programs. See every HealthTech & MedTech accelerator, or browse other verticals.
Get HealthTech & MedTech deadline alerts
One digest a week. Deadline alerts only for verticals you pick. Unsubscribe anytime.